Bristol-Myers Squibb
Business: Pharma & Medical Devices | Pharmaceutical Companies
Recent News About Bristol-Myers Squibb
-
Man lived in Kansas, so kick his asbestos claims out of NYC court, defendants say
NEW YORK (Legal Newsline) – Companies facing lawsuits in New York City’s controversial asbestos court are using U.S. Supreme Court decisions from recent years that prevented plaintiffs lawyers from suing in whatever court they felt like. -
District courts divided on whether landmark BMS decision applies to class actions; SCOTUS likely to decide
WASHINGTON (Legal Newsline) - Federal district courts are divided on whether a landmark U.S. Supreme Court decision on personal jurisdiction is applicable to class actions. -
Houston lawyer Lanier opens trial against J&J in St. Louis alleging asbestos in talcum powder caused ovarian cancer
ST. LOUIS - Just before Houston plaintiff attorney Mark Lanier wrapped up opening arguments Wednesday morning on behalf of 77 women claiming asbestos in talcum powder caused ovarian cancer he told jurors about a study of infants who had been born dead. -
No quit in trial bar after SCOTUS ruling, still filing lawsuits in favorite courts
WASHINGTON (Legal Newsline) – Since last year’s U.S. Supreme Court ruling that dealt a blow to forum-shopping personal injury attorneys, companies threatened with sprawling, 50-state litigation have not been forced into defending cases all over the country. -
Trial lawyer panel: Plaintiffs' lawyers adapting strategies to fit post-BristolMyersSquibb legal landscape
While the U.S. Supreme Court's Bristol Myers Squibb ruling has resulted in some big wins for businesses targeted by the plaintiffs' bar, new strategies and theories deployed by plaintiffs' lawyers may be blunting the further impact of that decision, despite high hopes from some it would largely thwart the ability of out-of-state plaintiffs to sue out-of-state defendants in a favorable court forum. -
Nev. woman files lawsuit against asbestos firm over ‘deceitful’ agreement in breast implant case
New York City law firm Weitz & Luxenberg PC and Bristol-Myers Squibb and Medical Engineering Corporation -- the makers of the implants at issue -- allegedly entered into a stipulated agreement, dismissing the woman’s case with prejudice. The woman claims the agreement was entered into without her knowledge and in direct contradiction to an agreed upon tolling agreement.